List of aTyr Pharma patents

Patents where

Current Assignee

Name

aTyr Pharma

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10093915 Histidyl-tRNA synthetase-Fc conjugates	Patent 10093915 was granted and assigned to aTyr Pharma on October, 2018 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	10093915	October 9, 2018
‌ US Patent 11072787 Histidyl-tRNA synthetase-Fc conjugates	Patent 11072787 was granted and assigned to aTyr Pharma on July, 2021 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	11072787	July 27, 2021
‌ US Patent 9587235 Histidyl-tRNA synthetase-Fc conjugates	Patent 9587235 was granted and assigned to aTyr Pharma on March, 2017 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	9587235	March 7, 2017
‌ US Patent 7572452 Method for stimulating wound healing	Patent 7572452 was granted and assigned to aTyr Pharma on August, 2009 by the United States Patent and Trademark Office.		aTyr Pharma	United States Patent and Trademark Office	7572452	August 11, 2009
‌ US Patent 9688978 Aspartyl-tRNA synthetase-Fc conjugates	Patent 9688978 was granted and assigned to aTyr Pharma on June, 2017 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	9688978	June 27, 2017
‌ US Patent 11505610 Compositions and methods comprising anti-NRP2 antibodies	Patent 11505610 was granted and assigned to aTyr Pharma on November, 2022 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	11505610	November 22, 2022
‌ US Patent 9328340 Amino acyl tRNA synthetases for modulating inflammation	Patent 9328340 was granted and assigned to aTyr Pharma on May, 2016 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	9328340	May 3, 2016
‌ US Patent 9540628 Aminoacyl tRNA synthetases for modulating inflammation	Patent 9540628 was granted and assigned to aTyr Pharma on January, 2017 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	9540628	January 10, 2017
‌ US Patent 9943577 Aminoacyl tRNA synthetases for modulating inflammation	Patent 9943577 was granted and assigned to aTyr Pharma on April, 2018 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	9943577	April 17, 2018
‌ US Patent 10711260 Histidyl-tRNA synthetase-Fc conjugates	Patent 10711260 was granted and assigned to aTyr Pharma on July, 2020 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	10711260	July 14, 2020
‌ US Patent 9404104 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of P38 multi-tRNA synthetase complex	Patent 9404104 was granted and assigned to aTyr Pharma on August, 2016 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	9404104	August 2, 2016
‌ US Patent 9896680 Compositions and methods comprising aspartyl-tRNA synthetases having non-canonical biological activities	Patent 9896680 was granted and assigned to aTyr Pharma on February, 2018 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	9896680	February 20, 2018
‌ US Patent 9062302 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex	Patent 9062302 was granted and assigned to aTyr Pharma on June, 2015 by the United States Patent and Trademark Office.		aTyr Pharma	United States Patent and Trademark Office	9062302	June 23, 2015
‌ US Patent 9714419 PEGylated tyrosyl-tRNA synthetase polypeptides	Patent 9714419 was granted and assigned to aTyr Pharma on July, 2017 by the United States Patent and Trademark Office.		aTyr Pharma	United States Patent and Trademark Office	9714419	July 25, 2017
‌ US Patent 9816084 Aspartyl-tRNA synthetases	Patent 9816084 was granted and assigned to aTyr Pharma on November, 2017 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	9816084	November 14, 2017
‌ US Patent 8404471 Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities	Patent 8404471 was granted and assigned to aTyr Pharma on March, 2013 by the United States Patent and Trademark Office.		aTyr Pharma	United States Patent and Trademark Office	8404471	March 26, 2013
‌ US Patent 9499810 Thrombopoietic activity of tyrosyl-tRNA synthetase polypeptides	Patent 9499810 was granted and assigned to aTyr Pharma on November, 2016 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	9499810	November 22, 2016
‌ US Patent 8828395 Antibodies that bind tyrosyl-tRNA synthetases	Patent 8828395 was granted and assigned to aTyr Pharma on September, 2014 by the United States Patent and Trademark Office.		aTyr Pharma	United States Patent and Trademark Office	8828395	September 9, 2014
‌ US Patent 9157076 Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities	Patent 9157076 was granted and assigned to aTyr Pharma on October, 2015 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	9157076	October 13, 2015
‌ US Patent 9453214 Polypeptide structural motifs associated with cell signaling activity	Patent 9453214 was granted and assigned to aTyr Pharma on September, 2016 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	9453214	September 27, 2016
‌ US Patent 9585946 Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities	Patent 9585946 was granted and assigned to aTyr Pharma on March, 2017 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	9585946	March 7, 2017
‌ US Patent 8747840 Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities	Patent 8747840 was granted and assigned to aTyr Pharma on June, 2014 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	8747840	June 10, 2014
‌ US Patent 7981426 Method for stimulating wound healing	Patent 7981426 was granted and assigned to aTyr Pharma on July, 2011 by the United States Patent and Trademark Office.		aTyr Pharma	United States Patent and Trademark Office	7981426	July 19, 2011
‌ US Patent 9127268 Aminoacyl tRNA synthetases for modulating inflammation	Patent 9127268 was granted and assigned to aTyr Pharma on September, 2015 by the United States Patent and Trademark Office.		aTyr Pharma	United States Patent and Trademark Office	9127268	September 8, 2015
‌ US Patent 9822353 PEGylated aspartyl-tRNA synthetase polypeptides	Patent 9822353 was granted and assigned to aTyr Pharma on November, 2017 by the United States Patent and Trademark Office.	aTyr Pharma	aTyr Pharma	United States Patent and Trademark Office	9822353	November 21, 2017

Results per page:

28 results

0 selected

28 results

0 selected